1. Market Research
  2. > Pathology
About 200 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Global Nuclear Medicine Market - Opportunities and Forecast (2013-2023)

  • $ 2400
  • January 2019
  • 244 pages

lymphoma where as samarium-##-EDTMP, and strontium-##-chloride for palliation of bone metastases.

  • Lymphoma
  • Mental Health
  • Pathology
  • World
  • Cardinal Health, Inc.

Global Medical Cannabis Market - Opportunities and Forecast (2014-2024)

  • $ 2400
  • March 2019
  • 290 pages

Figure ##: US New Cases of Cancer, By Type, 2018 (In %) ##. ##% ##. ##% ##. ##% ##. ##% ##. ##% ##. ##% ##. ##% ##. ##% ##. ##% Digestive System Respiratory System Skin Genital System Breast Urinary System Endocrine System Lymphoma Others Source: American Society of Cancer US MEDICAL CANNABIS MARKET, BY

  • Marijuana
  • Mental Health
  • Recreational Activity
  • World
  • Market Size

Global Central Nervous System Therapeutic Market - Opportunities and Forecast (2014-2024)

  • $ 2200
  • March 2019
  • 214 pages

There are several types of brain tumor depending upon the kind of cell which is infected such as gilomas, epidermoid, lymphoma, meningioma etc.

  • Health Services
  • Lymphoma
  • Mental Health
  • Neurology
  • World

Medical Marijuana - Thematic Research

  • $ 7995
  • November 2019
  • 186 pages

Medical Marijuana: Innovative Pipeline Shows Promise For Treating More Than ## Indications © GlobalData 2019 This product is licensed and is not to be photocopied.

  • Lymphoma
  • Marijuana
  • Mental Health
  • Neurological Disorder
  • Neurology

Global Genetic Disorders Drugs Market to 2023 - A Rapidly Growing Treatment Landscape Driven by Targeted Complement System Inhibitors and Enzyme Replacement Therapies to Treat PNH and Lysosomal Storage Disease

  • $ 4995
  • December 2017
  • 160 pages

They also have an increased risk of Parkinson' s disease, and cancers such as myeloma, leukemia and lymphoma.

  • Clinical Trial
  • Genetic Disorder
  • Lymphoma
  • Mental Health
  • Therapy

Analyzing the Global CNS Market 2018

  • $ 1000
  • April 2018
  • 175 pages

lymphoma; ZYTIGA (abiraterone acetate), a treatment for metastatic castration-resistant prostate cancer; IMBRUVICA (ibrutinib), an oral, oncedaily therapy approved for use in treating certain B-cell malignancies or blood cancers, and Waldenstrom' s Macroglobulinemia; PROCRIT (epoetin al

  • Infectious Disease
  • Lymphoma
  • Mental Health
  • Psychotic Disorder
  • Therapy

Global Myasthenia Gravis Drugs Market 2017-2021

  • $ 2500
  • January 2017
  • 73 pages

2017-2021 TECHNAVIO.

  • Mental Health
  • Neurological Disorder
  • Alexion Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Flamel Technologies S.A.

National Institute of Neurological Disorders and Stroke - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • September 2018
  • 68 pages

a postdoctoral fellow in the Lieberman Lab, received The Leukemia & Lymphoma Society Career Development Fellow Award for $##, ## over three years to support a research project on the functions of an Epstein-Barr virus protein called EBNA## in regulating host gene expression.

  • Lymphoma
  • Mental Health
  • Neurological Disorder
  • Stroke
  • United States

Gamma Secretase (EC 3.4.23.) - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 78 pages

As of September 2017, the drug candidate was in Phase I stage for T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma.

  • Hospital
  • Lymphoma
  • Mental Health
  • Pharmaceutical
  • Therapy

Brainstorm Cell Therapeutics, Inc. (USA)

  • $ 1500
  • January 2016
  • 32 pages

Lymphoma by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others.............. ## Table ##: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Lymphoproliferative by Region Worldwide (2015) - Percentage Market Share Breakdown by Val

  • Lymphoma
  • Mental Health
  • Stem Cell Transplant
  • Transplantation
  • Market Shares

AB Science SA (AB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 77 pages

About masitinib ##/ ##/ 2018: EPFL: Attacking lymphoma at the source The efficacy of target specific therapies in lymphoma is limited to subgroups of patients.

  • Dementia
  • Lymphoma
  • Mental Health
  • Therapy
  • AB Science SA

Tyrosine Protein Kinase Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kinase or p59 Fyn or FYN or EC 2.7.10.2) - Pipeline Review, H2 2018

  • $ 3500
  • November 2018
  • 79 pages

The efficacy of target specific therapies in lymphoma is limited to subgroups of patients.

  • Dementia
  • Lymphoma
  • Mental Health
  • Therapy
  • AB Science SA

Serine Protein Kinase ATM - Pipeline Review, H1 2020

  • $ 3500
  • January 2020
  • 35 pages

Lymphoma, Multiple Myeloma (Kahler Disease), Solid Tumor and Squamous Cell Carcinoma.

  • Lymphoma
  • Mental Health
  • Neurological Disorder
  • Therapy
  • AstraZeneca PLC

Teva Pharmaceutical Industries Limited - Product Pipeline Review - 2016

  • $ 1500
  • February 2016
  • 150 pages

CEP-## acts as an anaplastic lymphoma kinase (ALK) inhibitor.

  • Lymphoma
  • Mental Health
  • Pharmaceutical
  • Research And Development
  • United States

Serine Protein Kinase ATM - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 35 pages

Lymphoma, Multiple Myeloma (Kahler Disease), Solid Tumor and Squamous Cell Carcinoma.

  • Lymphoma
  • Mental Health
  • Neurological Disorder
  • Therapy
  • AstraZeneca PLC

Tyrosine Protein Kinase Fyn - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 103 pages

It is in Phase I/ II stage of development for metastatic breast cancer and for Mantle cell lymphoma, natural killer lymphoma, follicular lymphoma, marginal zone lymphoma, lymphoblastic lymphoma.

  • Dermatological Condition
  • Lymphoma
  • Mental Health
  • Therapy
  • AB Science SA

Tyrosine Protein Kinase Fyn - Pipeline Review, H1 2020

  • $ 3500
  • January 2020
  • 103 pages

It is in Phase I/ II stage of development for metastatic breast cancer and for Mantle cell lymphoma, natural killer lymphoma, follicular lymphoma, marginal zone lymphoma, lymphoblastic lymphoma.

  • Dermatological Condition
  • Lymphoma
  • Mental Health
  • Therapy
  • AB Science SA

Tyrosine Protein Kinase Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kinase or p59 Fyn or FYN or EC 2.7.10.2) - Pipeline Review, H1 2018

  • $ 3500
  • May 2018
  • 83 pages

The efficacy of target specific therapies in lymphoma is limited to subgroups of patients.

  • Lymphoma
  • Mental Health
  • Therapy
  • United States
  • AB Science SA

Down Syndrome - Pipeline Review, H2 2019

  • $ 2000
  • November 2019
  • 94 pages

The key objectives of the study were to assess safety and tolerability, pharmacokinetics, pharmacodynamics, and anti-lymphoma activity.

  • Dementia
  • Mental Health
  • Therapy
  • United States
  • Amgen Inc.

Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H1 2020

  • $ 2000
  • March 2020
  • 147 pages

It is in Phase II/ III stage of development for diffuse B-cell lymphoma, follicular lymphoma, nodal marginal zone lymphoma, refractory mantle cell lymphoma and extranodal marginal zone lymphoma.

  • Lymphoma
  • Mental Health
  • Neurological Disorder
  • Therapy
  • Alexion Pharmaceuticals, Inc.
View report >

Asthma Statistics in the UK

  • January 2017
  • 15 pages

Cancer Chart ##. ## shows the most common cancers for this age group are lymphomas, including cancer of the lymph system, Hodgkin Disease and non-Hodgkin Lymphoma, followed by carcinomas (malignant tumours on the surface or lining of a body organ).

  • Asthma
  • Lymphoma
  • Mental Health
  • United Kingdom
  • Diabetes UK

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on